Twist Bioscience
Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Genetic Testing
The partners will design multiple assay kits in an attempt to make genetic testing for rare diseases more accessible to patients.
Twist Bioscience, Adicet Bio Ink Cancer Collaboration; Barclays Initiates Twist Coverage
Twist will provide its single-chain variable fragment and single-domain VHH antibody (nanobody) technologies to discover unique target-specific binders.
A-Alpha Bio Raises $20M in Series A Financing
The startup said it has partnered with Twist Biopharma and Lumen Bioscience to use its yeast-based protein-protein interaction method in drug discovery.
Twist Bioscience, SomaLogic Partner on Antibodies, Target Discovery
Twist will use any antibodies discovered under the program for its internal pipeline, with the potential to license the most promising ones to a development partner.
Twist Bioscience Fiscal Q3 Revenues Grow 65 Percent
Twist said that healthcare is now the largest end market for its oligonucleotide products, representing nearly 50 percent of all revenues.
May 7, 2021
Feb 5, 2021